- Home
- UAMY vs ICCM Comparison
UAMY vs ICCM Comparison
Compare UAMY & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- ICCM
- Stock Information
- Founded
- UAMY 1968
- ICCM 2006
- Country
- UAMY United States
- ICCM Israel
- Employees
- UAMY N/A
- ICCM N/A
- Industry
- UAMY Metal Fabrications
- ICCM
- Sector
- UAMY Industrials
- ICCM
- Exchange
- UAMY Nasdaq
- ICCM Nasdaq
- Market Cap
- UAMY 67.5M
- ICCM 29.3M
- IPO Year
- UAMY N/A
- ICCM N/A
- Fundamental
- Price
- UAMY $0.67
- ICCM $0.57
- Analyst Decision
- UAMY
- ICCM Strong Buy
- Analyst Count
- UAMY 0
- ICCM 2
- Target Price
- UAMY N/A
- ICCM $2.70
- AVG Volume (30 Days)
- UAMY 715.3K
- ICCM 409.5K
- Earning Date
- UAMY 11-11-2024
- ICCM 11-13-2024
- Dividend Yield
- UAMY N/A
- ICCM N/A
- EPS Growth
- UAMY N/A
- ICCM N/A
- EPS
- UAMY N/A
- ICCM N/A
- Revenue
- UAMY $9,862,364.00
- ICCM $3,336,000.00
- Revenue This Year
- UAMY N/A
- ICCM $18.61
- Revenue Next Year
- UAMY N/A
- ICCM $54.91
- P/E Ratio
- UAMY N/A
- ICCM N/A
- Revenue Growth
- UAMY 18.08
- ICCM 3.60
- 52 Week Low
- UAMY $0.17
- ICCM $0.48
- 52 Week High
- UAMY $0.82
- ICCM $1.57
- Technical
- Relative Strength Index (RSI)
- UAMY 45.42
- ICCM 45.18
- Support Level
- UAMY $0.67
- ICCM $0.51
- Resistance Level
- UAMY $0.74
- ICCM $0.61
- Average True Range (ATR)
- UAMY 0.05
- ICCM 0.04
- MACD
- UAMY -0.01
- ICCM -0.00
- Stochastic Oscillator
- UAMY 10.20
- ICCM 64.19
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.